Ultragenyx Pharmaceutical Company
Developing therapies for rare and ultra-rare diseases
Investors
Technology:
Immunotherapy
Industry:
Gene Therapy
Headquarters:
California, United States
Founded Date:
2010-01-01
Employees Number:
501-1000
Funding Status:
IPO
Investors Number:
9
Total Funding:
185000005
Estimated Revenue:
$10M to $50M
Last Funding Date:
2016-06-07
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership